Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Comment by longondmxon Jan 03, 2016 4:23pm
101 Views
Post# 24426168

RE:Insider selling in the first-half of 2015, it's now clear

RE:Insider selling in the first-half of 2015, it's now clearWhile you may be right, given the relative small number of shares sold by insiders compared to their holdings, I wouldn't make much of it. I believe something positive will come out of the negotiations a that are supposedly taking place or I wouldn't be invested here. And that we will see a nice pop in share price.  The story is far from dead with Lumisort. In the meantime, enjoy the fact that the company is doing well in its core business.  

The fact that they are not diluting the company by issuing more shares should speak volumes to what's to come.   A $200,000 line is minimal and if they believe they don't need to issue more shares to get to the next leg, should be indication that something will come out soon


As with the release that they would be delaying their latest filings only to file the next day, we could see an announcement on lumisort any day. Whether that is tomorrow, in a month or whenever. You just don't know and in the meantime the business is not going anywhere. And likely their current share price is pretty safe from going much lower. 
Bullboard Posts